ARCHIVES

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Bypass Budget Seeks Double Funding for Breast Cancer Research

November 6, 1992

GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It

October 22, 1982

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

A. Lindo Patterson: Pioneer and Mentor

October 26, 2021

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978